Dr Paul Zollinger-Read is director of GP commissioning at NHS East of England and medical adviser at The King’s Fund.
- HSJ Knowledge
Clinical commissioning groups have an opportunity to reverse a declining trend, and take responsibility for the improvement of care quality, says Paul Zollinger-Read.
In 2012, the Year of the Dragon, will commissioning plans be all smoke and no fire? Paul Zollinger-Read says it is vital that they aren’t.
Now is a golden opportunity to start developing guidelines and principles to inform better healthcare delivery, says Paul Zollinger-Read
The big question nervously whispered in the shadows of the corridors of power is: “what will be different about clinically led commissioning?”. Many have sought the answer - few have found it. Paul Zollinger-Read sheds some light on the direction clinically led commissioning might take.
Followership: what sort of a word is that? Whatever it is, it has been troubling me for some time.
The NHS has made great strides in delivering safer services: the recent work on surgical check lists is another excellent example that hospitals cannot afford to ignore. However there is still much to do, says Paul Zollinger-Read.
Lessons from the States are often relegated to the ‘too different to be useful’ box, but on closer inspection there are many similarities between American medical groups and the proposed GP consortia – as Paul Zollinger-Read learned on a recent visit to Boston.
“Them and us”. All too often an off-hand remark and the death knell of a beautiful conversation, usually with the word “tariff” thrown in.